PB1904: TRIAL IN PROGRESS: A PHASE III STUDY OF ASCIMINIB VS AN INVESTIGATOR-SELECTED TKI IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP). (23rd June 2022) - Hughes, T.; Cortes, J.; Takahashi, N.; Larson, R.; Issa, G.; Bombaci, F.; Ramscar, N.; Kapoor, S.; Ifrah, S.; Hochhaus, A.